MGI Kicks Off ICG-17 in Riga with Launch of DNBSEQ-T7** HotMPS High-Throughput Sequencing Kit* and Spatial Transcriptomics Grant Program

Riga, Latvia – MGI Tech Co. Ltd. (MGI), in collaboration with BGI Genomics, BGI Research and the Latvian Biomedical Research and Study Centre, has brought the 17th International Conference of Genomics (ICG-17) to Europe this year on 7-9 September in Riga, Latvia. At ICG-17, MGI introduces its new commercial sequencing chemistry HotMPS* and together with BGI STOmics, a [...]

Benchling Launches the First Complete Solution for RNA R&D to Accelerate mRNA and RNA Therapeutics Development

Nearly half (44%) of top 50 biopharma companies are now involved in RNA work sparking new demand for tools purpose built for the full spectrum of RNA R&D. SAN FRANCISCO — Benchling, the R&D Cloud powering the biotechnology industry, today launched the industry’s first full set of capabilities for designing, modeling, and studying both natural and [...]

Carlyle Announces Formation of Atmas Health in Partnership with World-Class Healthcare Executives

New York, New York and Park City, Utah – Global investment firm Carlyle (NASDAQ: CG) announced today the formation of Atmas Health in partnership with long-time healthcare executives Kieran Gallahue, Jim Hinrichs, and Jim Prutow and Carlyle’s Global Healthcare team. Atmas Health, headquartered in Park City, Utah, will focus on acquiring healthcare assets within the medical [...]

High Q Technologies Inc. Hires Vice President, Research and Development and Announces Additional Recent Appointments to Support Rapid Growth

WATERLOO, Ontario -- High Q Technologies Inc. is an innovative life sciences tool company providing drug hunters and structural biologists with highly sensitive, quantum-enabled EPR systems to solve historically complex problems in protein dynamics. The company is pleased to announce the appointment of Andrew Wiles as Vice President of Research and Development, reporting directly to [...]

faCellitate, a BASF spin-off, closes a €3.7m seed round led by SARSTEDT and HTGF

Proprietary intelligent polymer surface coating platform enables development of first-in-class lab materials for modern cell culture applications Closing of seed round completed raising €3.7 million from SARSTEDT, High-Tech Gründerfonds (HTGF), R3 Consulting, ARVE Capital, ROI Verwaltungsgesellschaft and Chemovator. faCellitate has developed an intelligent and ultra-low attachment polymer surface coating platform. The first launched product thereof is [...]

Lunaphore and Nucleai announce a partnership to provide AI-powered spatial biology analysis to accelerate drug development

LAUSANNE, Switzerland and TEL AVIV, Israel – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, today announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest [...]

Zetta Genomics appoints Mark Bailey as CEO to lead drive for growth

Previously CEO at Fendix, Mark‘s understanding of the wider medtech industry means he is well-placed to accelerate Zetta’s global momentum.  Zetta Genomics, a pioneer in large-scale genomic data management, has appointed Mark Bailey as its chief executive officer. Bailey has been brought in to lead Zetta’s next phase of growth. Ludo Chapman, Chair of Zetta Genomics, commented: “We welcome Mark’s [...]

FDA Accepts Integral Molecular’s Letter of Intent (LOI) on Membrane Proteome Array Antibody Specificity Test Into ISTAND Drug Development Tools Pilot Program

PHILADELPHIA —Integral Molecular, the leader in antibody discovery against membrane proteins, has been accepted into the U.S. Food & Drug Administration (FDA)’s ISTAND pilot program. This program supports Innovative Science and Technology Approaches for New Drugs and was created to expand the drug development tool types listed in the 21st Century Cures legislation. A major goal [...]

SmartGene and Illumina Collaborate to Promote Broad Adoption of Next Generation Sequencing for Routine Testing Across Multiple Markets

Unterägeri, Switzerland _ SmartGene, a leading provider of bioinformatics Software-as-a-Service applications (SaaS Apps), today announced a new collaboration with Illumina, a global leader in DNA sequencing and array-based technologies, to enable broad adoption of Next Generation Sequencing (NGS) for routine analysis in infectious diseases and industrial markets. The scope of the collaboration includes clinical microbiology, food [...]

Oxford Nanopore and Al Jalila Children’s Specialty Hospital announce pilot programme to assess the potential utility of nanopore sequencing in unresolved rare disease cases

This partnership will use whole human genome sequencing to support actionable characterisation of rare genetic diseases.  Oxford Nanopore Technologies (Oxford Nanopore) and Al Jalila Children’s Specialty Hospital (AJCH) today announce a new partnership to investigate the potential utility of nanopore sequencing for children with unresolved rare genetic disorders. AJCH, the first and only dedicated children’s [...]

Access IBO on Knowledge Center